All terms in EFO
| Label | Id | Description |
|---|---|---|
| acute erythroleukemia | EFO_0000218 | [An acute myeloid leukemia characterized by a predominant immature erythroid population. There are two subtypes recognized: erythroleukemia and pure erythroid leukemia. (WHO, 2001)] |
| acute myeloid leukemia by FAB classification | MONDO_0015667 | [Acute myeloid leukemias that do not fulfill the criteria for inclusion in the group of acute myeloid leukemias which have recurrent genetic abnormalities or myelodysplastic changes, or are therapy-related. This category includes entities classified according to the French-American-British classification scheme.] |
| erythroid neoplasm | MONDO_0020703 | |
| obsolete_acute lymphoblastic leukemia | EFO_0000219 | [A neoplasm of immature malignant lymphocytes (lymphoblasts) committed to the B-cell or T-cell lineage. Neoplasms involving the bone marrow and the peripheral blood are called precursor lymphoblastic leukemias or acute lymphoblastic leukemias. Neoplasms involving primarily lymph nodes or extranodal sites are called lymphoblastic lymphomas. -- 2003] |
| bromobenzene | CHEBI_3179 | |
| obsolete_non-syndromic esophageal malformation | Orphanet_108959 | |
| Streptococcus oralis | NCBITaxon_1303 | |
| YCC6 | EFO_0002881 | |
| Streptococcus gordonii | NCBITaxon_1302 | |
| cardiotonic drug | CHEBI_38147 | [A drug that has a strengthening effect on the heart or that can increase cardiac output.] |
| YCC3 | EFO_0002880 | |
| lymphoid leukemia | EFO_0004289 | [A malignant lymphocytic neoplasm of B-cell or T-cell lineage involving primarily the bone marrow and the peripheral blood. This category includes precursor or acute lymphoblastic leukemias and chronic leukemias.] |
| non-Hodgkins lymphoma | EFO_0005952 | [Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.] |
| precursor lymphoblastic lymphoma/leukemia | EFO_0009119 | [A neoplasm of immature malignant lymphocytes (lymphoblasts) committed to the B-cell or T-cell lineage. Neoplasms involving the bone marrow and the peripheral blood are called precursor lymphoblastic leukemias or acute lymphoblastic leukemias. Neoplasms involving primarily lymph nodes or extranodal sites are called lymphoblastic lymphomas. -- 2003] |
| neoplasm of immature B and T cells | EFO_0002425 | [A neoplasm arising from immature B and T cells] |
| haemopoietic system cell line | EFO_0002883 | [Cell lines that are part of the haemopoietic system.] |
| Streptococcus thermophilus | NCBITaxon_1308 | |
| YCC7 | EFO_0002882 | |
| acute monocytic leukemia | EFO_0000221 | [Acute monoblastic leukemia (AML-M5), is one of the most common subtypes of acute myeloid leukemia (AML) that is either comprised of more than 80% of monoblasts (AML-M5a) or 30-80% monoblasts with (pro)monocytic differentiation (AML-M5b). AML-M5 presents with asthenia, pallor, fever, and dizziness. Specific features of AML-M5 include hyperleukocytosis, propensity for extramedullary infiltrates, coagulation abnormalities including disseminated intravascular coagulation and neurological disorders. Leukemia cutis and gingival infiltration can also be seen. A characteristic translocation observed in AML-M5 is t(9;11).] |
| Streptococcus suis | NCBITaxon_1307 |